Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cardiff Oncology, Inc. (CRDF) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cardiff Oncology, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1213037.
Total stock buying since 2015: $11,735,176.
Total stock sales since 2015: $662,755.
Total stock option exercises since 2015: $464,803.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 290,000 | $710,500 | 0 | $0 | 0 | $0 |
| 2024 | 379,331 | $1,011,143 | 0 | $0 | 0 | $0 |
| 2023 | 30,000 | $41,100 | 0 | $0 | 0 | $0 |
| 2022 | 228,000 | $379,443 | 0 | $0 | 28,858 | $75,030 |
| 2021 | 88,695 | $695,598 | 0 | $0 | 330 | $0 |
| 2020 | 597,165 | $824,529 | 35,321 | $657,005 | 36,832 | $87,596 |
| 2019 | 0 | $0 | 0 | $0 | 12,813 | $0 |
| 2018 | 61,200 | $51,020 | 0 | $0 | 396,252 | $0 |
| 2017 | 0 | $0 | 8,334 | $5,750 | 131,686 | $0 |
| 2016 | 357,188 | $1,064,461 | 0 | $0 | 75,639 | $302,177 |
| 2015 | 1,192,730 | $6,957,382 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 290,000 | $710,500 | 0 | $0 | 0 | $0 |
| 2024-12 | 379,331 | $1,011,143 | 0 | $0 | 0 | $0 |
| 2023-12 | 30,000 | $41,100 | 0 | $0 | 0 | $0 |
| 2022-11 | 10,000 | $14,300 | 0 | $0 | 0 | $0 |
| 2022-09 | 218,000 | $365,143 | 0 | $0 | 0 | $0 |
| 2022-07 | 0 | $0 | 0 | $0 | 28,858 | $75,030 |
| 2021-09 | 60,000 | $397,020 | 0 | $0 | 0 | $0 |
| 2021-03 | 28,695 | $298,578 | 0 | $0 | 0 | $0 |
| 2021-01 | 0 | $0 | 0 | $0 | 330 | $0 |
| 2020-11 | 0 | $0 | 35,321 | $657,005 | 35,321 | $87,596 |
| 2020-09 | 2,550 | $14,535 | 0 | $0 | 0 | $0 |
| 2020-05 | 594,615 | $809,994 | 0 | $0 | 0 | $0 |
| 2020-01 | 0 | $0 | 0 | $0 | 1,511 | $0 |
| 2019-10 | 0 | $0 | 0 | $0 | 1,250 | $0 |
| 2019-07 | 0 | $0 | 0 | $0 | 1,250 | $0 |
| 2019-04 | 0 | $0 | 0 | $0 | 1,250 | $0 |
| 2019-01 | 0 | $0 | 0 | $0 | 9,063 | $0 |
| 2018-10 | 0 | $0 | 0 | $0 | 7,500 | $0 |
| 2018-06 | 61,200 | $51,020 | 0 | $0 | 0 | $0 |
| 2018-01 | 0 | $0 | 0 | $0 | 388,752 | $0 |
| 2017-09 | 0 | $0 | 8,334 | $5,750 | 81,686 | $0 |
| 2017-01 | 0 | $0 | 0 | $0 | 50,000 | $0 |
| 2016-12 | 34,716 | $71,248 | 0 | $0 | 0 | $0 |
| 2016-11 | 322,472 | $993,213 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-30 | Pace Gary W | Buy | 290,000 | 2.45 | 710,500 |
| 2024-12-18 | Levine James E. (Chief Financial Officer) | Buy | 2,400 | 5.00 | 12,000 |
| 2024-12-17 | Levine James E. (Chief Financial Officer) | Buy | 2,752 | 5.42 | 14,904 |
| 2024-12-16 | Levine James E. (Chief Financial Officer) | Buy | 2,564 | 3.83 | 9,820 |
| 2024-12-12 | Tannenbaum Renee P | Buy | 10,000 | 3.42 | 34,220 |
| 2024-12-11 | Pace Gary W | Buy | 361,615 | 2.60 | 940,199 |
| 2023-12-19 | Pace Gary W (Director) | Buy | 30,000 | 1.37 | 41,100 |
| 2022-11-25 | Erlander Mark (Chief Executive Officer) | Buy | 10,000 | 1.43 | 14,300 |
| 2022-09-19 | White Lale | Buy | 15,000 | 1.64 | 24,525 |
| 2022-09-16 | Levine James E. (Chief Financial Officer) | Buy | 30,000 | 1.56 | 46,710 |
| 2022-09-16 | Armitage James O | Buy | 13,000 | 1.56 | 20,228 |
| 2022-09-15 | Tannenbaum Renee P | Buy | 10,000 | 1.72 | 17,180 |
| 2022-09-15 | Pace Gary W | Buy | 150,000 | 1.71 | 256,500 |
| 2022-07-05 | White Lale | Option Ex | 28,858 | 2.60 | 75,030 |
| 2021-09-21 | Pace Gary W | Buy | 30,000 | 6.75 | 202,500 |
| 2021-09-10 | Levine James E. (Chief Financial Officer) | Buy | 30,000 | 6.48 | 194,520 |
| 2021-03-26 | Markin Rodney S | Buy | 2,900 | 10.32 | 29,933 |
| 2021-03-23 | Kelemen Vicki (Exec. VP and COO) | Buy | 960 | 10.31 | 9,897 |
| 2021-03-23 | Erlander Mark (Chief Executive Officer) | Buy | 965 | 10.34 | 9,980 |
| 2021-03-23 | Jacob Gary S | Buy | 2,370 | 10.41 | 24,669 |
| 2021-03-23 | Pace Gary W | Buy | 10,000 | 10.24 | 102,400 |
| 2021-03-22 | Brancaccio John P | Buy | 3,000 | 10.95 | 32,850 |
| 2021-03-19 | Armitage James O | Buy | 4,000 | 10.82 | 43,272 |
| 2021-03-18 | Pace Gary W | Buy | 3,000 | 10.56 | 31,680 |
| 2021-03-04 | Pace Gary W | Buy | 1,500 | 9.27 | 13,897 |
| 2021-01-02 | Kelemen Vicki (Exec. VP and COO) | Option Ex | 70 | .00 | 0 |
| 2021-01-02 | Erlander Mark (Chief Executive Officer) | Option Ex | 260 | .00 | 0 |
| 2020-11-23 | Kelemen Vicki (Exec. VP and COO) | Sale | 35,321 | 18.60 | 657,005 |
| 2020-11-23 | Kelemen Vicki (Exec. VP and COO) | Option Ex | 35,321 | 2.48 | 87,596 |
| 2020-09-16 | Pace Gary W | Buy | 2,550 | 5.70 | 14,535 |
| 2020-05-14 | Erlander Mark (Chief Executive Officer) | Buy | 6,993 | 1.43 | 9,999 |
| 2020-05-14 | White Lale (Director) | Buy | 69,930 | 1.43 | 99,999 |
| 2020-05-14 | Markin Rodney S (Director) | Buy | 20,979 | 1.43 | 29,999 |
| 2020-05-14 | Armitage James O (Director) | Buy | 10,490 | 1.43 | 15,000 |
| 2020-05-14 | Brancaccio John P (Director) | Buy | 6,993 | 1.43 | 9,999 |
| 2020-05-14 | Jacob Gary S (Director) | Buy | 17,483 | 1.43 | 25,000 |
| 2020-05-14 | Adams Thomas Phd (Director) | Buy | 13,986 | 1.43 | 19,999 |
| 2020-05-11 | Pace Gary W (Director) | Buy | 447,761 | 1.34 | 599,999 |
| 2020-01-02 | Erlander Mark (Chief Scientific Officer) | Option Ex | 261 | .00 | 0 |
| 2020-01-01 | Erlander Mark (Chief Scientific Officer) | Option Ex | 1,250 | .00 | 0 |
| 2019-10-01 | Erlander Mark (Chief Scientific Officer) | Option Ex | 1,250 | .00 | 0 |
| 2019-07-01 | Erlander Mark (Chief Scientific Officer) | Option Ex | 1,250 | .00 | 0 |
| 2019-04-01 | Erlander Mark (Chief Scientific Officer) | Option Ex | 1,250 | .00 | 0 |
| 2019-01-02 | Erlander Mark (Chief Scientific Officer) | Option Ex | 1,563 | .00 | 0 |
| 2019-01-01 | Erlander Mark (Chief Scientific Officer) | Option Ex | 7,500 | .00 | 0 |
| 2018-10-01 | Erlander Mark (Chief Scientific Officer) | Option Ex | 7,500 | .00 | 0 |
| 2018-06-20 | Markin Rodney S (Director) | Buy | 41,200 | .85 | 35,020 |
| 2018-06-08 | Tennant Stanley (Director) | Buy | 10,000 | .80 | 8,000 |
| 2018-06-08 | Brancaccio John P (Director) | Buy | 10,000 | .80 | 8,000 |
| 2018-01-30 | Erlander Mark (Chief Scientific Officer) | Option Ex | 90,000 | .00 | 0 |
| 2018-01-30 | Welch William J (Chief Executive Officer) | Option Ex | 130,000 | .00 | 0 |
| 2018-01-02 | Erlander Mark (Chief Scientific Officer) | Option Ex | 18,750 | .00 | 0 |
| 2018-01-02 | Billings Paul (Director) | Option Ex | 16,667 | .00 | 0 |
| 2018-01-02 | Tennant Stanley (Director) | Option Ex | 16,667 | .00 | 0 |
| 2018-01-02 | Markin Rodney S (Director) | Option Ex | 16,667 | .00 | 0 |
| 2018-01-02 | Brancaccio John P (Director) | Option Ex | 16,667 | .00 | 0 |
| 2018-01-02 | Jacob Gary S (Director) | Option Ex | 16,667 | .00 | 0 |
| 2018-01-02 | Welch William J (Chief Executive Officer) | Option Ex | 50,000 | .00 | 0 |
| 2018-01-02 | Adams Thomas Phd (Director) | Option Ex | 16,667 | .00 | 0 |
| 2017-09-05 | Tennant Stanley (Director) | Sale | 8,334 | .69 | 5,750 |
| 2017-09-02 | Erlander Mark (Chief Scientific Officer) | Option Ex | 30,001 | .00 | 0 |
| 2017-09-02 | Billings Paul (Director) | Option Ex | 6,498 | .00 | 0 |
| 2017-09-02 | Tennant Stanley (Director) | Option Ex | 8,484 | .00 | 0 |
| 2017-09-02 | Markin Rodney S (Director) | Option Ex | 5,943 | .00 | 0 |
| 2017-09-02 | Brancaccio John P (Director) | Option Ex | 12,667 | .00 | 0 |
| 2017-09-02 | Jacob Gary S (Director) | Option Ex | 9,287 | .00 | 0 |
| 2017-09-02 | Adams Thomas Phd (Director) | Option Ex | 8,806 | .00 | 0 |
| 2017-01-02 | Erlander Mark (Chief Scientific Officer) | Option Ex | 50,000 | .00 | 0 |
| 2016-12-19 | Tennant Stanley (Director) | Buy | 10,000 | 2.10 | 21,000 |
| 2016-12-16 | Tennant Stanley (Director) | Buy | 14,966 | 2.00 | 29,932 |
| 2016-12-16 | Welch William J (CEO) | Buy | 4,750 | 2.09 | 9,941 |
| 2016-12-14 | Erlander Mark (Chief Scientific Officer) | Buy | 5,000 | 2.08 | 10,375 |
| 2016-11-11 | Mignone Roberto | Buy | 322,472 | 3.08 | 993,213 |
| 2016-04-21 | Zaniboni Steve (Former CFO) | Option Ex | 75,639 | 4.00 | 302,177 |
| 2015-08-12 | Tennant Stanley (Director) | Buy | 10,000 | 6.06 | 60,599 |
| 2015-08-12 | Zaniboni Steve (CFO) | Buy | 15,000 | 5.43 | 81,450 |
| 2015-08-12 | Schuh Antonius (CEO) | Buy | 20,000 | 5.45 | 109,000 |
| 2015-07-17 | Mignone Roberto | Buy | 140,000 | 8.75 | 1,225,000 |
| 2015-04-02 | Mignone Roberto | Buy | 300,000 | 6.90 | 2,070,000 |
| 2015-02-27 | Mignone Roberto | Buy | 79,343 | 5.62 | 445,907 |
| 2015-02-26 | Mignone Roberto | Buy | 78,801 | 5.42 | 427,101 |
| 2015-02-25 | Mignone Roberto | Buy | 105,142 | 5.12 | 538,327 |
| 2015-02-06 | Mignone Roberto | Buy | 444,444 | 4.50 | 1,999,998 |
Insider trading activities including stock purchases, stock sales, and option exercises of CRDF listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cardiff Oncology, Inc. (symbol CRDF, CIK number 1213037) see the Securities and Exchange Commission (SEC) website.